Amit Sachdev - 01 Mar 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Director
Signature
/s/ Amit Sachdev
Issuer symbol
EIGR
Transactions as of
01 Mar 2023
Transactions value $
$0
Form type
4
Filing time
03 Mar 2023, 19:50:28 UTC
Previous filing
28 Feb 2023
Next filing
14 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +28K $0.00 28K 01 Mar 2023 Common Stock 28K $1.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date.